Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole.1996 · 83 citations
2. 2Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients1996 · 117 citations
3. 3Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement2007 · 170 citations
4. 4Trends in prescribing H2‐receptor antagonists and proton pump inhibitors in primary care1998 · 50 citations
5. 5Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression2009 · 94 citations